Skip to main content
. 2023 May 2;14:1180336. doi: 10.3389/fimmu.2023.1180336

Figure 3.

Figure 3

Therapeutic potential of microbiota-directed treatments in COVID-19. Microbiota-targeted therapies, including FMT, probiotics and traditional Chinese medicine, may reverse gut microbiota dysbiosis and play a protective role in antagonizing SARS-CoV-2 infection and pathogenesis. FMT, faecal microbiota transplantation; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; ACE2, angiotensin-converting enzyme 2.